157 related articles for article (PubMed ID: 17956671)
1. [Establishment of multiple myeloma mouse models expressing brain derived neurotrophic factor].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):967-72. PubMed ID: 17956671
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of anti-brain derived neurotrophic factor monoclonal antibody in human multiple myeloma xenograft animal model.
Wang YD; Hu Y; Huang J; Zhang L; Sun CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1069-72. PubMed ID: 18928597
[TBL] [Abstract][Full Text] [Related]
4. Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma.
Hu Y; Wang YD; Guo T; Wei WN; Sun CY; Zhang L; Huang J
Cancer Genet Cytogenet; 2007 Oct; 178(1):1-10. PubMed ID: 17889702
[TBL] [Abstract][Full Text] [Related]
5. [Establishment of xenotransplated mouse model using primary multiple myeloma cells].
Liu CY; Zhang L; Wang N; Wang D; Geng Z; Xu DM; Li CR; Zhou JF; Huang L
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):195-9. PubMed ID: 22781606
[TBL] [Abstract][Full Text] [Related]
6. NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.
Lawson MA; Paton-Hough JM; Evans HR; Walker RE; Harris W; Ratnabalan D; Snowden JA; Chantry AD
PLoS One; 2015; 10(3):e0119546. PubMed ID: 25768011
[TBL] [Abstract][Full Text] [Related]
7. Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo.
Ai LS; Sun CY; Wang YD; Zhang L; Chu ZB; Qin Y; Gao F; Yan H; Guo T; Chen L; Yang D; Hu Y
Int J Cancer; 2013 Sep; 133(5):1074-84. PubMed ID: 23420490
[TBL] [Abstract][Full Text] [Related]
8. Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma: a potential in vivo culture system.
Huang SY; Tien HF; Su FH; Hsu SM
Am J Pathol; 2004 Feb; 164(2):747-56. PubMed ID: 14742278
[TBL] [Abstract][Full Text] [Related]
9. [Study of brain-derived neurotrophic factor activating TrkB signaling cascades in the pathogenesis of multiple myeloma].
Sun CY; Hu Y; Guo T; Huang J; Zhang L; Chu ZB
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):238-42. PubMed ID: 18843977
[TBL] [Abstract][Full Text] [Related]
10. Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.
Schueler J; Wider D; Klingner K; Siegers GM; May AM; Wäsch R; Fiebig HH; Engelhardt M
PLoS One; 2013; 8(11):e79939. PubMed ID: 24223204
[TBL] [Abstract][Full Text] [Related]
11. The use of animal models in multiple myeloma.
Libouban H
Morphologie; 2015 Jun; 99(325):63-72. PubMed ID: 25898798
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouse.
Araki K; Sangai T; Miyamoto S; Maeda H; Zhang SC; Nakamura M; Ishii G; Hasebe T; Kusaka H; Akiyama T; Tokuda Y; Nagai K; Minami H; Ochiai A
Int J Cancer; 2006 May; 118(10):2602-8. PubMed ID: 16353147
[TBL] [Abstract][Full Text] [Related]
13. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of brain-derived neurotrophic factors and receptors in multiple myeloma].
Sun CY; Hu Y; Wu T; Wang YD; He WJ
Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):906-9. PubMed ID: 16409727
[TBL] [Abstract][Full Text] [Related]
15. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.
Huang YW; Richardson JA; Tong AW; Zhang BQ; Stone MJ; Vitetta ES
Cancer Res; 1993 Mar; 53(6):1392-6. PubMed ID: 8443818
[TBL] [Abstract][Full Text] [Related]
16. [Human multiple myeloma cell line RPMI8226 activates brain derived neurotrophic factor autocrine loop of co-cultured endothelial cells].
Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):235-8. PubMed ID: 17877199
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of a multiple myeloma local tumor model in mice].
Liu Y; Zhou MY; Meng WT; Xu CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):647-51. PubMed ID: 20561420
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of human retinoblastoma model in human immune reconstruction non-obese diabetic-severe combine immunodeficient mice].
Zhong XF; Ge J; Peng FH; Zhang B; Lin JX; Zhang WX; Li YP
Zhonghua Yan Ke Za Zhi; 2007 Aug; 43(8):739-43. PubMed ID: 18001574
[TBL] [Abstract][Full Text] [Related]
19. Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice.
Hjorth-Hansen H; Seifert MF; Börset M; Aarset H; Ostlie A; Sundan A; Waage A
J Bone Miner Res; 1999 Feb; 14(2):256-63. PubMed ID: 9933480
[TBL] [Abstract][Full Text] [Related]
20. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]